InspireMD (NSPR) Net Income towards Common Stockholders Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.19% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 64.73% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 30.89% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 60.12% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 29.56% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn | 97.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 97.19% |
| Sep 30, 2025 | -42.30% |
| Jun 30, 2025 | -41.08% |
| Mar 31, 2025 | -36.75% |
| Dec 31, 2024 | 84.70% |
| Sep 30, 2024 | -27.62% |
| Jun 30, 2024 | -33.05% |
| Mar 31, 2024 | -31.74% |
| Dec 31, 2023 | -16.03% |
| Sep 30, 2023 | -36.96% |
| Jun 30, 2023 | -28.93% |
| Mar 31, 2023 | -29.42% |
| Dec 31, 2022 | -23.89% |
| Sep 30, 2022 | -29.82% |
| Jun 30, 2022 | -28.09% |
| Mar 31, 2022 | -11.80% |
| Dec 31, 2021 | -21.45% |
| Sep 30, 2021 | -26.50% |
| Jun 30, 2021 | -50.25% |
| Mar 31, 2021 | -10.72% |
| Dec 31, 2020 | 12.00% |
| Sep 30, 2020 | -1.71% |
| Jun 30, 2020 | -2.63% |
| Mar 31, 2020 | 7.57% |
| Dec 31, 2019 | -3.75% |
| Sep 30, 2019 | -1.24% |
| Jun 30, 2019 | -4.27% |
| Mar 31, 2019 | -12.51% |
| Dec 31, 2018 | 7.46% |
| Sep 30, 2018 | 17.95% |
| Jun 30, 2018 | 35.64% |
| Mar 31, 2017 | 24.59% |
| Sep 30, 2016 | 20.33% |
| Jun 30, 2016 | 49.32% |
| Mar 31, 2016 | 22.75% |
| Dec 31, 2015 | -14.13% |
| Sep 30, 2015 | 21.43% |
| Mar 31, 2014 | -46.58% |
| Sep 30, 2013 | -67.00% |
| Jun 30, 2013 | -182.50% |